A Bengali Dietary Salt Study to Control Blood Pressure

Barts & The London NHS Trust

Status and phase: Completed; Phase 3

Conditions: Hypertension

Treatments: Behavioral: Low-salt educational programme; Behavioral: Low-salt Bangladeshi educational programme

Study type: Interventional

Funder types: Other

Identifiers

NCT00702312

07/Q0605/13

Details and patient eligibility

About

The aim of this study is to assess the benefits of using low-salt and healthy eating educational programme, designed specifically for Bangladeshi kidney patients, compared to the usual diet advice given by the clinic dietitians.

Full description

We conducted an exploratory study initially to learn about the East London Bangladeshi (ELB) kidney patients salt intake. Furthermore, we assessed their educational needs to inform the development and implementation of an educational programme to reduce dietary salt intake in line with the Department of Health recommendations for a good blood pressure control. The educational programme will be tested in a randomized controlled trial. We are interested in salt because studies have shown that salt is one of the causes of high blood pressure. Scientific studies have also shown that the longer a person has high blood pressure the more the damage to the kidneys.

Enrollment: 56 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult Bengali kidney disease hypertensive patients

Exclusion criteria

• Non-hypertensive Bengali patients and those on dialysis therapy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

56 participants in 2 patient groups

Study group

Experimental group

Description:

Study group that will attend low-salt educational community programme

Treatment:

Behavioral: Low-salt Bangladeshi educational programme

Behavioral: Low-salt educational programme

Behavioral: Low-salt Bangladeshi educational programme

Control group

No Intervention group

Description:

Subjects in this arm will have routine medical and dietetic treatment for low-salt reduction.